BioAtla (BCAB) Share-based Compensation (2020 - 2026)

BioAtla (BCAB) has reported Share-based Compensation for 7 consecutive years, with $619000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Share-based Compensation fell 89.53% year-over-year to $619000.0; the trailing twelve-month figure through Jun 2026 stood at $4.6 million (down 21.76% YoY), and the FY2025 full-year result was $5.4 million, down 39.09% from the prior year.
• Share-based Compensation eased to $619000.0 in Q2 2026 per BCAB's latest filing, from $956000.0 in the prior quarter.
• Across five years, Share-based Compensation topped out at $6.6 million in Q2 2023 and bottomed at $619000.0 in Q2 2026.
• Historically, Share-based Compensation has averaged $4.3 million across 5 years, with a median of $4.9 million in 2022.
• The sharpest annual moves came in 2023 and 2026: Share-based Compensation jumped 77.32% in 2023, then plunged 89.53% in 2026.
• Over 5 years, Share-based Compensation stood at $3.5 million in 2022, then decreased by 21.79% to $2.7 million in 2023, then dropped by 29.47% to $1.9 million in 2024, then slumped by 42.0% to $1.1 million in 2025, then slumped by 44.73% to $619000.0 in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $619000.0, $956000.0, and $1.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.